Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Estrov

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Seminars in Hematology|July 1, 1993
Interruption of autocrine and paracrine growth-stimulatory mechanisms: a new therapeutic strategy for chronic myelogenous leukemiaZ Estrov
Leukemia & Lymphoma|June 28, 2001
The clinical significance of caspase regulation in acute leukemiaS Faderl, Z Estrov
The New England Journal of Medicine|January 23, 1999
Detection of residual disease in childhood acute lymphoblastic leukemiaS Faderl, Z Estrov
Leukemia & Lymphoma|February 1, 1997
Role of interleukin-1 beta converting enzyme (ICE) in acute myelogenous leukemia cell proliferation and programmed cell deathZ Estrov, M Talpaz
Hematology/Oncology Clinics of North America|January 9, 2001
Studies of minimal residual disease in acute lymphocytic leukemiaW Stock, Z Estrov
Experimental Hematology|October 1, 1983
Enhancement of hemopoietic stem cell proliferation by prostaglandin inhibitory drugsZ Estrov, P Resnitzky
Harefuah|January 15, 1990
[Hematopoietic growth factors and their clinical application]Z Estrov, P Resnitzky
Cytokines and Molecular Therapy|March 1, 1996
Role of interleukin-1 beta converting enzyme (ICE) in leukemiaZ Estrov, M Talpaz
Cytokines, Cellular & Molecular Therapy|July 29, 1998
Residual disease in acute lymphoblastic leukemia of childhood: methods of detection and clinical relevanceS Faderl, Z Estrov
Critical Reviews in Oncology/Hematology|August 26, 1998
The clinical significance of detection of residual disease in childhood ALLS Faderl, Z Estrov
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Seminars in Hematology|July 1, 1993
Interruption of autocrine and paracrine growth-stimulatory mechanisms: a new therapeutic strategy for chronic myelogenous leukemiaZ Estrov
Leukemia & Lymphoma|June 28, 2001
The clinical significance of caspase regulation in acute leukemiaS Faderl, Z Estrov
The New England Journal of Medicine|January 23, 1999
Detection of residual disease in childhood acute lymphoblastic leukemiaS Faderl, Z Estrov
Leukemia & Lymphoma|February 1, 1997
Role of interleukin-1 beta converting enzyme (ICE) in acute myelogenous leukemia cell proliferation and programmed cell deathZ Estrov, M Talpaz
Hematology/Oncology Clinics of North America|January 9, 2001
Studies of minimal residual disease in acute lymphocytic leukemiaW Stock, Z Estrov
Experimental Hematology|October 1, 1983
Enhancement of hemopoietic stem cell proliferation by prostaglandin inhibitory drugsZ Estrov, P Resnitzky
Harefuah|January 15, 1990
[Hematopoietic growth factors and their clinical application]Z Estrov, P Resnitzky
Cytokines and Molecular Therapy|March 1, 1996
Role of interleukin-1 beta converting enzyme (ICE) in leukemiaZ Estrov, M Talpaz
Cytokines, Cellular & Molecular Therapy|July 29, 1998
Residual disease in acute lymphoblastic leukemia of childhood: methods of detection and clinical relevanceS Faderl, Z Estrov
Critical Reviews in Oncology/Hematology|August 26, 1998
The clinical significance of detection of residual disease in childhood ALLS Faderl, Z Estrov
Pageof 19